SynCore Biotechnology Co.,Ltd (TPEX:4192)
Taiwan · Delayed Price · Currency is TWD 24.00
-0.40 (-1.64%)
Jan 22, 2026, 1:10 PM CST
TPEX:4192 Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 171.28 | 205.49 | 264.7 | 269.15 | 552.97 | 539.23 | Upgrade |
Trading Asset Securities | 7.04 | 6.96 | 6.66 | 6.66 | 6.66 | 6.66 | Upgrade |
Cash & Short-Term Investments | 178.32 | 212.44 | 271.36 | 275.81 | 559.63 | 545.89 | Upgrade |
Cash Growth | -18.03% | -21.71% | -1.61% | -50.72% | 2.52% | 38.90% | Upgrade |
Accounts Receivable | 5.71 | 2.37 | 2.7 | 1.91 | 1.81 | 1.17 | Upgrade |
Other Receivables | 33.16 | 32.78 | 31.69 | 30.87 | 30.27 | 5.13 | Upgrade |
Receivables | 38.86 | 35.15 | 34.4 | 32.78 | 32.08 | 6.29 | Upgrade |
Inventory | 9.07 | 10.06 | 3.13 | 36.4 | 114.04 | 157.15 | Upgrade |
Prepaid Expenses | 1.51 | 2.39 | 1.46 | 2.71 | 3.73 | 4.25 | Upgrade |
Other Current Assets | 0.43 | 0.42 | 0.13 | 0.54 | 1.22 | 28.4 | Upgrade |
Total Current Assets | 228.19 | 260.46 | 310.48 | 348.23 | 710.71 | 741.98 | Upgrade |
Property, Plant & Equipment | 5.49 | 9.48 | 4.63 | 14.81 | 11.12 | 27.83 | Upgrade |
Long-Term Investments | - | 3.91 | 12.08 | 15.09 | 20.36 | 27.85 | Upgrade |
Other Intangible Assets | 38.72 | 43.89 | 51.11 | 58.47 | 82.21 | 116.29 | Upgrade |
Other Long-Term Assets | 0.45 | 0.06 | 0.06 | 0.04 | 0.04 | 0.04 | Upgrade |
Total Assets | 272.85 | 317.8 | 378.36 | 436.65 | 824.44 | 913.99 | Upgrade |
Accounts Payable | 4.74 | 9.51 | 0.16 | 0.87 | 0.16 | 14.03 | Upgrade |
Accrued Expenses | 3.28 | 3.93 | 16.96 | 114.13 | 252.26 | 107.92 | Upgrade |
Short-Term Debt | - | - | - | 60 | 120 | 180 | Upgrade |
Current Portion of Long-Term Debt | - | - | - | - | - | 30 | Upgrade |
Current Portion of Leases | 4.38 | 6.8 | 1.95 | 10.21 | 5.3 | 13.19 | Upgrade |
Other Current Liabilities | 1.83 | 1.89 | 2.15 | 1.43 | 3.8 | 2.98 | Upgrade |
Total Current Liabilities | 14.88 | 22.12 | 21.23 | 186.64 | 381.52 | 348.12 | Upgrade |
Long-Term Leases | - | 0.99 | - | 0.99 | - | 5.3 | Upgrade |
Total Liabilities | 14.88 | 23.11 | 21.23 | 187.64 | 381.52 | 353.41 | Upgrade |
Common Stock | 351.65 | 351.65 | 351.65 | 1,151 | 1,151 | 1,066 | Upgrade |
Additional Paid-In Capital | 12.62 | 66.91 | 105.08 | - | 263.5 | 257.88 | Upgrade |
Retained Earnings | -69.95 | -54.28 | -38.17 | -843.33 | -918.16 | -717.44 | Upgrade |
Comprehensive Income & Other | -36.35 | -69.58 | -61.42 | -58.43 | -53.19 | -45.63 | Upgrade |
Shareholders' Equity | 257.97 | 294.69 | 357.14 | 249.01 | 442.92 | 560.58 | Upgrade |
Total Liabilities & Equity | 272.85 | 317.8 | 378.36 | 436.65 | 824.44 | 913.99 | Upgrade |
Total Debt | 4.38 | 7.79 | 1.95 | 71.2 | 125.3 | 228.49 | Upgrade |
Net Cash (Debt) | 173.94 | 204.66 | 269.4 | 204.6 | 434.34 | 317.41 | Upgrade |
Net Cash Growth | -16.12% | -24.03% | 31.67% | -52.89% | 36.84% | -1.28% | Upgrade |
Net Cash Per Share | 4.95 | 5.82 | 8.40 | 6.65 | 14.31 | 11.41 | Upgrade |
Filing Date Shares Outstanding | 35.17 | 35.17 | 35.17 | 30.74 | 30.74 | 28.47 | Upgrade |
Total Common Shares Outstanding | 35.17 | 35.17 | 35.17 | 30.74 | 30.74 | 28.47 | Upgrade |
Working Capital | 213.32 | 238.34 | 289.26 | 161.59 | 329.19 | 393.86 | Upgrade |
Book Value Per Share | 7.34 | 8.38 | 10.16 | 8.10 | 14.41 | 19.69 | Upgrade |
Tangible Book Value | 219.25 | 250.79 | 306.03 | 190.54 | 360.71 | 444.29 | Upgrade |
Tangible Book Value Per Share | 6.24 | 7.13 | 8.70 | 6.20 | 11.73 | 15.60 | Upgrade |
Machinery | 39.5 | 39.41 | 39.2 | 38.78 | 39.53 | 39.26 | Upgrade |
Leasehold Improvements | 18.38 | 18.38 | 18.38 | 18.38 | 18.38 | 18.38 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.